Back to Newsroom
Back to Newsroom

Trans Global Group, Inc. Corporate Updates

Wednesday, 27 September 2017 02:45 PM

Trans Global Group Inc.

Topic:

COCONUT CREEK, FL / ACCESSWIRE / September 27, 2017 / Trans Global Group, Inc. (OTC PINK: TGGI) will release several news items over the coming weeks allowing the market time to digest Cannabis Consortium's scope.

Share Structure Reductions:

In August 2017, Trans Global Group, Inc., the parent Company of Cannabis Consortium, Inc. ("Cannabis"), initiated an extended restructuring phase to reduce the total number of Authorized shares and the total number of shares traded in the Float. To date, TGGI has successfully reduced its Authorized shares by over 2.7 billion Common shares and successfully reduced its Float by 300 million Common shares. There are two further planned reductions that will occur over the next few weeks that will reduce the number of free trading shares in the Float by an additional 530 million Common shares.

TGGI has already developed detailed plans for further reductions in the Float totaling 3 billion shares, and possibly more, once all the corporate actions for its Cannabis Consortium subsidiary have been completed.

Cannabis Consortium, Inc.:

Cannabis Consortium, Inc. ("Cannabis") is a subsidiary company that was purchased by TGGI in 2010 to create an active trading subsidiary. Cannabis itself was created in 1998 as a Blank Check Shell and currently has 47 shareholders.

Cannabis has already spoken with, and will be retaining, Counsel during October 2017 to prepare and file a Reg A so it can then begin to access capital markets as a separate trading entity from TGGI.

Once the Reg A has been approved, Cannabis will work with a Market Maker to file a Form 15c-211 so the Company can independently trade under its own name and ticker symbol.

TGGI and its shareholders will remain the majority shareholder within Cannabis.

When Cannabis begins trading as its own separate entity, a plan will be presented to TGGI shareholders allowing them to exchange a portion of their TGGI shares for Cannabis shares. This action is intended to expand the shareholder base of Cannabis and simultaneously both reduce TGGI's Outstanding shares, and TGGI's Float.

MJ Licenses:

Cannabis Consortium intends to apply for MJ licenses in several U.S. states, beginning with, but not limited to, Colorado. After the Colorado licenses have been approved, Cannabis plans to execute Joint Venture agreements in other states where cannabis has already been legalized.

For the purposes of expediting the business plan and in order to quickly move to a revenue generation phase, the business lines are being structured in a manner that allows Cannabis to effect sales without immediately requiring MJ licenses.

Business Lines:

Cannabis Consortium is comprised of four (4) revenue streams compromising specialty items, foodstuffs, beverages, and one (1) research division. Three (3) of the revenue streams are derived from edibles and the other revenue stream is derived from investments. The research division will focus on the medical benefits of CBD oils for the treatment of animals.

Specialty Items:

For our specialty items, Cannabis is retaining Counsel to file several patents and trademarks on the products the Company has already designed.

A company Cannabis came across during its due diligence phase on potential acquisitions has an item that was being used in a specific non-MJ sector application. This item had sold millions of units at approximately $10 retail per unit and $1-$2 wholesale. Cannabis felt that this price point would broadly fit the expectations of its intended market.

Rather than acquire the patent holding company and its live patent, Cannabis recognized an opportunity existed to design a series of brand new and very different products in a manner that would allow for future patent applications in both the MJ and non-MJ sectors.

Cannabis has completed the design of several specialty products that are a markedly different solution to the specific technological problems processes and materials, offered by the product Cannabis passed on.

The differences, both individually and combined, should allow for a series of patent applications to be filed by Cannabis and be successfully granted by the U.S. Patent and Trademark Office (USPTO).

Cannabis will additionally apply for a series of Trademarks to USPTO to register and protect the brand names and logos, as applicable.

More information regarding the statements made in this release along with more information about Cannabis Consortium will be released in the coming days.

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:

Matt Dwyer
[email protected]
954-905-9896

SOURCE: Trans Global Group, Inc.

Topic:
Back to newsroom
Back to Newsroom
Share by: